Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages

Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages

Computed tomography (CT) scans are the gold standard to measure treatment success of non-small cell lung cancer (NSCLC) therapies. Here, we investigated the very early tumor response of patients receiving chemotherapy or targeted therapies using a panel of already established and explorative liquid...

Full description

Bibliographic Details
Main Authors: Florian Janke, Farastuk Bozorgmehr, Sabine Wrenger, Steffen Dietz, Claus P. Heussel, Gudula Heussel, Carlos F. Silva, Stephan Rheinheimer, Manuel Feisst, Michael Thomas, Heiko Golpon, Andreas Günther, Holger Sültmann, Thomas Muley, Sabina Janciauskiene, Michael Meister, Marc A. Schneider
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
NSCLC
early response biomarkers
liquid biomarkers
targeted therapy
chemotherapy
Online Access:https://www.mdpi.com/2072-6694/12/4/954

Internet

https://www.mdpi.com/2072-6694/12/4/954

Similar Items